CYTK·Cytokinetics Incorporated
CYTK|Analyst Targets
CYTK|Insider Trading
CYTK|Fundamentals
CYTK|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $-1.43 | - | - |
| Q3'25 | $-1.57 | $-1.54 | +1.6% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $41M | - | - |
| Q3'25 | - | $2M | - |
CYTK|Monthly Returns
Market Data
CYTK Stock Snapshot
- Market cap
- 8.49B
- Day range
- $60.15 – $62.05
- News sentiment
- 50/100 · Neutral
- Analyst target
- $109.90 (+79.8%)
- Consensus
- Buy · 30 analysts
The trend on CYTK is bearish, and the indicator set is confirming it rather than diverging. At this size, a single catalyst moves the stock further than it would a larger peer.
Behaviour On Record
What CYTK's own history says about today's numbers
- Realized volatility (21d)
- 32.8% 6th pct
- Below its peak
- -28.1%
- vs 200-day average
- -10.5%
- Up days (1y)
- 47%
Cytokinetics Incorporated is currently running 32.8% annualised volatility over the last 21 sessions. Measured against CYTK's own 13 years of daily returns rather than a market-wide average, that is the 6th percentile — unusually subdued by its own history, against a typical reading of 53.0%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.
CYTK is trading -28.1% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -41.6%, and the deepest was -76.8% in 2014. The current pullback is therefore shallower than what this stock gives back in a typical year, which is context worth having before treating it as a dislocation.
Price sits -10.5% from its 200-day moving average. Against every other day in its history, that gap ranks at the 24th percentile — a narrower gap than it typically runs. Over the past year CYTK closed higher on 47% of sessions, and it is currently 2 sessions into a falling streak.
On October specifically: over 13 years of records, CYTK finished the month higher 6 of 13 times, with a median return of -3.1% and an average of -1.8%. Its strongest month historically has been December at +9.9% on average, its weakest September at -4.1%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.
Overnight risk is measurable too: CYTK has opened more than 2% away from the prior close in 413 of 3,224 sessions (12.8% of the time), with the largest gaps running +21.6% and -32.4%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.
All figures computed from 3,226 daily closes between 2013-10-07 and 2026-10-05, split-adjusted, recomputed daily. Percentiles are against CYTK's own 13-year history, not a peer group or index.
Sector Rotation
Is money rotating into or out of CYTK's sector?
Cytokinetics Incorporated sits in the Health Care sector, currently ranked 3rd of 12 GICS sectors by relative-strength rotation score (lagging). Within its narrower Biotechnology industry group, CYTK ranks 10th of 15 tracked industries, lagging.
- Sector rank
- #3 of 12
- Sector state
- Lagging
- Sector rotation score
- 64
- Industry rank
- #10 of 15
Analyst Rating Changes
Are analysts turning bullish or bearish on CYTK?
HC Wainwright & Co. most recently reiterated its rating on Cytokinetics Incorporated to Buy on Aug 31, 2026 with a price target of $140. Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.
- Latest action
- HC Wainwright & Co. — Buy
- 90-day upgrades
- 0
- 90-day downgrades
- 0
- Net rating momentum
- 0
Held by These ETFs
News Sentiment Analysis
Sentiment gathered from recent headlines
Recent News Coverage
Most recent articles, ranked by recency (click to expand).
Technical Analysis
Real-time indicators across multiple timeframes
| Manager | Trend | Shares Held | % of Co. | Position Value | Filed |
|---|---|---|---|---|---|
| Citadel Advisors LLC | • Hold | 1,966,745 | 1.42% | $167.55M | 2026-09-02 |
| Sarissa Capital Management LP | • Hold | 588,357 | 0.42% | $19.44M | 2025-08-14 |
| Member | Chamber | State | Type | Amount | Traded | Filed |
|---|---|---|---|---|---|---|
| Lisa McClain | House | MI09 | ▲ Buy | $1K - $15K | 2025-06-11 | 2025-08-13 |